25 of the Best Transplant Surgeons Near Me in South Carolina, US

Dr. Brian Houston is a cardiologist specializing in the management of advanced heart failure, including the care of patients before and after heart transplantation or left ventricular assist device (LVAD). After graduating from Emory University School of Medicine, Dr. Houston completed residency at Johns Hopkins Hospital in Baltimore, Maryland. He was invited to serve as an assistant chief of service of the Thayer Firm at Johns Hopkins Hospital, and he spent that year caring for patients and instructing residents and medical students. He remained at Johns Hopkins for his general cardiology fellowship and spent an additional year of fellowship there training in the care of advanced heart failure, LVADs, and transplantation. Dr. Houston has been invited to present his research work at international scientific meetings. He has a particular interest in cardiac sarcoidosis and in the effects of LVAD support on the gastrointestinal tract, blood, and the right side of the heart. He was honored to be named a finalist for the American Heart Association's Young Clinician Award in 2015. Dr. Houston believes that each patient with heart failure is unique and that, to live their best life, they require a caring and comprehensive approach from a dedicated medical team. Dr. Houston is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Sarcoidosis, Heart Failure, Pulmonary Hypertension, Heart Transplant, and Cardiac Ablation. Dr. Houston is currently accepting new patients.

Dr. Tedford is a Professor of Medicine/Cardiology and holds the Dr. Peter C. Gazes Endowed Chair in Heart Failure at the Medical University of South Carolina (MUSC) in Charleston, SC. He currently serves as the section head of heart failure and medical director of cardiac transplantation. He also established and directs the Advanced Heart Failure and Transplant Fellowship Program at MUSC. Dr. Tedford is an internationally recognized clinical researcher and has published over 200 peer-reviewed original research manuscripts, invited expert reviews, editorials and book chapters. His research efforts are focused on hemodynamic assessment of right ventricle function and its interaction with the pulmonary circulation and left heart. This research spans the fields of pulmonary hypertension, left heart disease, exercise physiology, hemodynamics, systemic sclerosis and mechanical circulatory support. He participates on several scientific advisory boards, clinical trial steering committees, and serves as a hemodynamic core laboratory for clinical pharmaceutical trials. He is co-chair of the PH due to left heart disease task force for 7^th^ World Symposium on Pulmonary Hypertension. He is a deputy editor for the *Journal of Heart and Lung Transplantation* and serves on the editorial board for *Circulation: Heart Failure CHEST*and *JACC: Heart* *Failure.*. Dr. Tedford is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Hypertension, Heart Failure, Heart Transplant, and Cardiac Ablation. Dr. Tedford is currently accepting new patients.

Dr. Sheldon E. Litwin is a cardiologist with nationally recognized expertise in advanced cardiac imaging and its use in the diagnosis of heart disease and treatment of patients with heart disease. Dr. Litwin is board-certified in general cardiology, nuclear cardiology, echocardiography, and cardiovascular computed tomography (CT). He was recognized in 2014 in America's Top Doctors (Castle Connolly Medical Ltd.). He is a strong proponent of preventive cardiology and has a longstanding interest in weight loss as prevention and treatment for cardiovascular disease. He is an avid outdoorsman and exercise advocate who is passionate about caring for active adults who participate in sports or recreational exercise. Prior to coming to MUSC Health, Dr. Litwin was chief of the division of cardiology at Georgia Regents University from 2011 to 2014 and director of cardiac imaging at the University of Utah from 1993 to 2011. Dr. Litwin is involved in clinical trials using new therapies for heart failure with preserved ejection fraction (HFpEF). He has published more than 100 scientific papers and serves on several editorial boards and national committees.Dr. Litwin's medical degree was awarded by Washington University School of Medicine. He completed a residency at the University of Arizona and completed a cardiology fellowship at Beth Israel Hospital, Harvard Medical School. Dr. Litwin is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Cardiomyopathy, Gastric Bypass, and Cardiac Ablation. Dr. Litwin is currently accepting new patients.

Dr. Jan Griffin completed her residency in internal medicine at the University of North Carolina in Chapel Hill and cardiology fellowship at Johns Hopkins Hospital. She then did a fellowship in advanced heart failure and transplant cardiology at Columbia University Irving Medical Center, where she continued as an assistant professor of medicine.Her research focuses on infiltrative cardiomyopathies, particularly cardiac amyloidosis and cardiac sarcoidosis. She is ABIM board certified in internal medicine, cardiology and advanced heart failure and transplant cardiology. Dr. Griffin is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Cardiac Amyloidosis, Primary Amyloidosis, Sarcoidosis, Cardiomyopathy, and Heart Transplant. Dr. Griffin is currently accepting new patients.

Dr. Zile is a graduate of Rush University School of Medicine. He did his internal medicine residency at Rush Presbyterian St. Lukes Medical Center in Chicago, a clinical cardiology fellowship at Tufts-New England Medical Center in Boston and a research cardiology fellowship at the Department of Veterans Affairs Medical Center, Boston. Dr. Zile is currently the Charles Ezra Daniel professor of medicine at the Medical University of South Carolina.He also serves as the director of cardiology at the Ralph H. Johnson Department of Veteran's Affairs Medical Center in Charleston. He is an adjunct professor of bioengineering at Clemson University.Dr. Zile's research career has involved both basic laboratory research examining the mechanisms of disease development and progression and translational clinical research examining the application of these basic mechanisms to development of effective treatment methods.Dr. Zile is a recognized leader in the areas of cardiac function, congestive heart failure, diastolic heart failure and valvular heart disease. His research is supported by grants from the National Heart, Lung and Blood Institute, the American Heart Association, the Department of Veterans Affairs and the Medical University of South Carolina.Dr. Zile is the author of over 100 peer-reviewed publications. He is a member of a number of professional societies including the American College of Physicians, American Federation of Clinical Research, American Heart Association, American College of Cardiology, the Heart Failure Society of America, International Society of Heart Failure, and the American Physiology Society. Dr. Zile has served on the research, educational and program committees of these organizations. He serves on the editorial boards of the Journal of the American College of Cardiology and Circulation and is an editorial consultant to a number of others including Circulation Research, Journal of Clinical Investigation and the American Journal of Physiology. Dr. Zile is a member of the Association of University Cardiologists and a member of the ABIM Subspecialty Board on Cardiovascular Disease. Dr. Zile is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Hypertensive Heart Disease, Pacemaker Implantation, and Cardiac Ablation. Dr. Zile is currently accepting new patients.

Dr. Daniel Judge is a professor of medicine in cardiology at MUSC. He received his medical degree at the University of Pennsylvania, and did his post-graduate training in internal medicine, cardiology, and advanced heart failure/transplant cardiology at Johns Hopkins. He is board-certified in both cardiology and advanced heart failure/transplant cardiology.Dr. Judge takes care of adult patients with inherited forms of cardiovascular disease, as well as congestive heart failure. As director of the cardiovascular genetics program, Dr. Judge has extensive experience caring for individuals and families with inherited forms of cardiomyopathy, aortic aneurysm, amyloidosis, and cardiac involvement from other genetic conditions.He has authored more than 150 scientific manuscripts. Dr. Judge is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Transthyretin Amyloid Cardiomyopathy, Cardiac Amyloidosis, Heart Transplant, and Cardiac Ablation. Dr. Judge is currently accepting new patients.

Barry Feldman is a Transplant Surgeon practicing medicine in Columbia, South Carolina. Dr. Feldman is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Arrhythmias, Sick Sinus Syndrome, Pacemaker Implantation, and Heart Bypass Surgery. Dr. Feldman is board certified in American Board Of Internal Medicine. Dr. Feldman is currently accepting new patients.

Derek Dubay is a Transplant Surgeon practicing medicine in Greenville, South Carolina. Dr. Dubay is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Liver Failure, Fibrolamellar Carcinoma, Necrosis, Kidney Transplant, and Liver Transplant. Dr. Dubay is currently accepting new patients.

Dr. Adrian Van Bakel graduated from the University of Louisville School of Medicine in 1981, completing a Ph.D. in pharmacology from that institution in 1983. He completed internal medicine residency and cardiology fellowship training at the Medical University of South Carolina and has been on the faculty at MUSC since 1991. Dr. Van Bakel served as the Medical Director of the Heart Failure and Cardiac Transplant Program from 1991-2017. He has been an integral part of a multi-disciplinary clinical team that has achieved excellent results in the areas of clinical heart failure management and cardiac transplantation. He is a member of a number of professional societies including: The American College of Physicians; the American Heart Association; the American College of Cardiology; the Heart Failure Society of America; and, the International Society of Heart and Lung Transplantation. He has served as a manuscript reviewer for several journals, such as: The Journal of Cardiac Failure; The Journal of Heart and Lung Transplantation; and, The American Journal of Transplantation. Dr. Van Bakel has been the principal investigator of many multi-center clinical trials in congestive heart failure and cardiac transplantation. His research interests include congestive heart failure management, novel immunosuppression strategies and the pharmacogenomics of drug absorption and metabolism. Dr. Van Bakel is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Pulmonary Edema, Heart Failure, Arrhythmogenic Right Ventricular Cardiomyopathy, Cardiac Ablation, and Endoscopy. Dr. Van Bakel is currently accepting new patients.

Dr. Chakradhari Inampudi M.D. is an advanced heart failure and transplant cardiologist and an assistant professor in the Department of Medicine. He specializes in treating patients with all forms of heart failure, pulmonary hypertension, including patients with advanced heart failure requiring IV medications, left ventricular assist devices (LVAD), and cardiac transplantation. Dr. Inampudi earned his medical degree at Kurnool Medical college, India. He then completed residency training in Internal medicine at Medical University of South Carolina where he was awarded the Golden Apple Award for excellence in teaching and clinical acumen. Dr. Inampudi completed fellowship training in cardiovascular diseases at University of Iowa Carver College of Medicine and subspecialty fellowship training in advanced heart failure and transplant cardiology at Vanderbilt University Medical center. Dr. Inampudi clinical and research interests are focused on strategies and therapies to improve outcomes and quality of life for patients with all forms of heart failure by implementing treatment systems to improve clinical outcomes and also also understanding the intersection of kidney and cardiovascular disease. This involves research through clinical trials and through examining data from real-world clinical practice on use and dosing of evidence-based heart failure medications, management of worsening heart failure outside the hospital and Improving outcomes following a hospitalization for heart failure. Dr. Inampudi believes that each patient with heart failure is unique and that a comprehensive approach from a dedicated medical team is essential to achive optimal outcomes. Dr. Inampudi is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Heart Failure, Cardiogenic Shock, Arrhythmogenic Right Ventricular Cardiomyopathy, Heart Transplant, and Cardiac Ablation. Dr. Inampudi is currently accepting new patients.

Prabhakar Baliga, M.D. FACS is a transplant surgeon and chair of the MUSC Department of Surgery, where he leads a diverse range of programs and services spanning nine clinical divisions, in addition to the Department's research and education divisions. Dr. Baliga's philosophy is to treat his patients with a primary focus on excellence and compassionate care. His clinical focus is in abdominal organ transplant with a special interest in kidney, liver and pancreas transplantation. He treats patients who are experiencing kidney failure, particularly with polycystic kidney disease; liver failure, liver cancer and patients who have issues with their bile duct, a series of thin tubes that go from the liver to the small intestine. ,He has served many leadership positions that have positively impacted the growth and expertise of the MUSC Health transplant program, the only solid organ transplant center in South Carolina. Prior to assuming the role of Department Chair, Dr. Baliga was named MUSC's ICCE Leader for Transplant, Nephrology & Hepatology and served on the Board of Life Point, an organ procurement agency. He has also served on the board for the United Network for Organ Sharing and the board of directors for the South Carolina chapter of the National Kidney Foundation. He is on the leadership of the state-wide SC surgical quality collaborative that is focused on improving care of surgical patients across SC. He currently serves on the American College of Surgeons Board of Governors as the Surgical Specialty Society Governor from the Southern Surgical Association.Dr. Baliga was awarded his medical degree by Madras Medical College in India. He completed his surgical residency at Tulane University and his transplant fellowship at the University of Michigan. Dr. Baliga is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Polycystic Kidney Disease, End-Stage Renal Disease (ESRD), Obesity, Kidney Transplant, and Pancreas Transplant. Dr. Baliga is currently accepting new patients.

Dr. Scalea is a board-certified surgeon specializing in kidney, pancreas, liver, and islet cell transplantation. Dr. Scalea's patient care philosophy is to treat his patients with a meticulous focus on excellence and compassionate care. His clinical area of expertise is in abdominal organ transplantation, with a special interest in kidney, pancreas, and islet cell transplantation. Dr. Scalea has achieved outstanding results in his simultaneous kidney and pancreas (SPK) transplant recipients. At MUSC Health, he is the Surgical Director of the Kidney Transplant Program and the Director of Hepatology, Nephrology, and Transplant ICCE Quality and Innovation.Dr. Scalea's research interests focus on improving outcomes and access to care for patients needing life-saving transplantation and researching strategies to achieve immune tolerance in allogeneic solid organ transplantation. He received international notoriety in 2019 for pioneering drones for organ transplants. As the inaugural Vice Chair of Surgery for Innovation, Dr. Scalea will expand his experience in clinical medicine, academic leadership, commercialization, and innovation to help translate innovative ideas from the laboratory to industry.Dr. Scalea received his medical degree and surgical training from the University of Maryland and completed his transplant fellowship at the University of Wisconsin and his post-doctoral fellowship at the Harvard Medical School, Transplantation Biology Research Center.When not in the clinic or laboratory, Dr. Scalea enjoys painting and performing music. His artworks are currently on display in Baltimore and Washington, D.C. Dr. Scalea is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Chronic Antibody-Mediated Rejection, Polycystic Kidney Disease, End-Stage Renal Disease (ESRD), Pancreas Transplant, and Kidney Transplant. Dr. Scalea is board certified in American College Of Surgeons. Dr. Scalea is currently accepting new patients.

Todd Merchen is a Transplant Surgeon practicing medicine in Greenville, South Carolina. Dr. Merchen is highly rated in 2 conditions, according to our data. His clinical expertise encompasses End-Stage Renal Disease (ESRD), Chronic Antibody-Mediated Rejection, Pyogenic Liver Abscess, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant.

John Mcgillicuddy is a Transplant Surgeon practicing medicine in Charleston, South Carolina. Dr. Mcgillicuddy is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Liver Failure, Chronic Antibody-Mediated Rejection, Fibrolamellar Carcinoma, Kidney Transplant, and Liver Transplant.

Dr. Ira Willner is an associate professor of medicine in the Division of Gastroenterology and Hepatology at the Medical University of South Carolina. He is also the director of the fellowship training program for gastroenterology and hepatology. Dr. Willner completed his medical degree (M.D.) at the SUNY Health Science Center in Syracuse, New York in 1990. He then completed a two-year fellowship in gastroenterology at the New York Medical College in Valhalla, New York in 1995, followed by a one-year fellowship in liver disease at the University of Tennessee in 1996. He is board certified in internal medicine and gastroenterology. Dr. Willner is a member of several professional organizations, including the American Association for the Study of Liver Disease, European Association for the Study of the Liver, American College of Physicians, American Medical Association, and the American College of Gastroenterology. Additionally, Dr. Willner was awarded the Department of Internal Medicine attending of the year in 2000. Dr. Willner's clinical interests include liver disease, treatment of portal hypertension, and viral hepatitis. Dr. Willner is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Hepatitis, Enlarged Liver, Endoscopy, and Liver Transplant. Dr. Willner is currently accepting new patients.

Dr. Luca Paoletti received his BA in biology from the University of Virginia and his medical degree from St. George's University. He completed internship and residency in internal medicine at the University of Connecticut Medical Center, where he was selected to serve as chief resident. He completed sub-specialty training in pulmonary and critical care medicine at the Medical University of South Carolina, where he is currently an associate professor of medicine and is the Medical Director of the Adult ECMO program and the Medical Director of Pulmonary Rehabilitation. His teaching activities and patient care are focused in the area of pulmonary transplant medicine. Dr. Paoletti is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Bronchiolitis Obliterans, Idiopathic Pulmonary Fibrosis, Lung Transplant, and Bone Marrow Aspiration. Dr. Paoletti is currently accepting new patients.

David Koch, MD, MSCR, specializes in Gastroenterology & Hepatology, and Liver Transplant. Dr. Koch is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Liver Failure, Cirrhosis, Hepatitis, Liver Transplant, and Endoscopy. Dr. Koch is currently accepting new patients.

Heather N. Simpson, M.D. is a transplant hepatologist and has been practicing as an Assistant Professor since 2013. She is board certified in Internal Medicine, Gastroenterology, and Transplant Hepatology. Dr. Simpson completed her undergraduate and medical school at Saint Louis University and graduated with her M.D. in 2005. She did her internship and residency in Internal Medicine at the University of Michigan. She obtained a gastroenterology fellowship at the Medical University of South Carolina. She then elected to pursue a year of additional training in transplant hepatology at the University of Michigan which she completed in 2013. Dr. Simpson belongs to several professional societies including the American Association for the Study of Liver Diseases, the American Society for Transplantation, and the International Liver Cancer Association. Her areas of expertise include management of all general liver diseases such as viral hepatitis B \& C, autoimmune liver disease, PBC, PSC, alcoholic liver disease, and non-alcoholic fatty liver disease, as well as the management of complications from cirrhosis. She has particular interests in the treatment of hepatocellular cancer and liver transplantation. Dr. Simpson is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Visceromegaly, Enlarged Liver, Ascites, and Endoscopy. Dr. Simpson is currently accepting new patients.

Timothy Whelan, MD, specializes in Critical Care Medicine, Lung Transplant, and Pulmonology and is located in Greenville, SC. Dr. Whelan is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Cholesterol Pneumonia, Hypersensitivity Pneumonitis, Bone Marrow Aspiration, and Lung Transplant. Dr. Whelan is currently accepting new patients.

Dr. McCann is a Heart Failure Cardiologist emphasizing a comprehensive therapeutic methodology to heart failure. After graduating from Southern Illinois University School of Medicine, Dr. McCann completed internal medicine residency at Saint Louis University. He was invited to serve as Chief Resident providing patient care and instructing residents and medical students. He remained at Saint Louis University for his general cardiology fellowship. Subsequently, he completed his advanced heart failure and transplant fellowship at University of California in San Diego.Dr. McCann then served as the medical director of heart failure, cardiac intensive care unit and left ventricular assist device programs at PRISMA Health. He established the first heart failure accountable care unit in South Carolina. He also developed one of the largest pulmonary artery pressure monitoring programs in the nation as a clinical assistant professor at the University of South Carolina.Additionally, he served over 20 years in the Air National Guard where he was the lead flight surgeon for the Critical Care Air Transport Team (CCATT) at McEntire Joint National Guard Base. Dr. McCann is an internationally recognized clinical researcher. He participates on several scientific advisory boards and clinical trial steering committees. He has a keen interest in remote management to help improve access to care and proactively care for his patients.Dr. McCann believes each patient with heart failure is unique and providing optimal care requires a tailored, multidisciplinary approach. Dr. Mccann is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Heart Failure, Pulmonary Edema, Heart Failure with Preserved Ejection Fraction (HFpEF), Patent Foramen Ovale Repair, and Pacemaker Implantation. Dr. Mccann is currently accepting new patients.

Dr. Anthony Carnicelli, M.D. is an advanced heart failure and transplant cardiologist and an assistant professor in the Department of Medicine. He specializes in treating patients with all forms of heart failure, including patients with advanced heart failure requiring IV medications, left ventricular assist devices (LVAD), and cardiac transplantation.Dr. Carnicelli earned his medical doctorate degree at the University of Rochester School of Medicine, where he was elected into the Alpha Omega Alpha (AOA) honor medical society. He completed residency training in internal medicine at Harvard Medical School's Brigham and Women's Hospital, where he was awarded the Golden Stethoscope Award for excellence in teaching and clinical acumen. Dr. Carnicelli completed fellowship training in cardiovascular diseases at Duke University as well as advanced training in clinical research at Duke Clinical Research Institute and subspecialty fellowship training in advanced heart failure and transplant cardiology at Duke University.Dr. Carnicelli's clinical interests include cardiovascular critical care, cardiogenic shock, cardiac catheterization, temporary and durable mechanical circulatory support, and cardiac transplantation. He has authored over 30 peer-reviewed original research manuscripts and has been awarded grant funding from the NIH to support his work. Dr. Carnicelli is passionate about teaching and enjoys working with medical students, residents, and fellows. Dr. Carnicelli is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Cardiogenic Shock, Heart Failure, Heart Attack, Atrial Fibrillation, and Heart Transplant. Dr. Carnicelli is currently accepting new patients.

Alexander Coltoff, M.D. received his medical degree from SUNY Downstate College of Medicine. He then completed his internal medicine residency at the Icahn School of Medicine at Mount Sinai, followed by a fellowship in Hematology/Oncology at New York Presbyterian - Columbia, both in New York. His clinical and research focus is on hematologic malignancies, particularly myeloproliferative neoplasms (MPNs), acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS). He has been published as a clinical investigator and received an American Society of Hematology (ASH) award for developing research scientists. Dr. Coltoff is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant.

Dr. Gregory Jackson is a specialist in advanced heart failure and transplant cardiology. He graduated from the University of Florida with highest honors before receiving his medical degree from the George Washington University School of Medicine and Health Sciences. He completed internal medicine residency training at the Cleveland Clinic, then completed his cardiology fellowship at the Medical University of South Carolina where he served as chief fellow. Dr. Jackson went on to complete the advanced heart failure and transplantation fellowship at the University of North Carolina-Chapel Hill before returning to MUSC as an assistant professor of medicine in the Division of Cardiology.Dr. Jackson is board certified in advanced heart failure and transplant cardiology, cardiovascular disease, echocardiography, and internal medicine. He is a Fellow of the American College of Cardiology (FACC), Fellow of the Heart Failure Society of America (FHFSA), and member of the International Society of Heart and Lung Transplant. He has been an invited speaker, as well as presented his research, at state and national conferences. Dr. Jackson's clinical interests include heart failure, left ventricular assist devices, cardiac transplantation, echocardiography, and cardiac catheterization, and his research interests include the intersection of sleep apnea and cardiovascular disease. Dr. Jackson is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Heart Failure, and Cardiogenic Shock. Dr. Jackson is currently accepting new patients.

Dr. Thomas DiSalvo attended Harvard College and graduated with honors from the University of Cincinnati College of Medicine. Following medical residency and chief residency at Johns Hopkins Hospital in Baltimore and serving on faculty at Johns Hopkins School of Medicine, he completed fellowship training in cardiology at the Massachusetts General Hospital and Harvard Medical School. After ten years of clinical practice as an assistant professor of medicine at Harvard, he was recruited as medical director of the Vanderbilt Heart and Vascular Institute and as associate professor of medicine at Vanderbilt. In 2015, Dr. DiSalvo was recruited as professor of medicine and chief of the division of cardiology at MUSC. Throughout his career, he has been an active and busy clinical cardiologist committed to the highest standards of excellence. As an educator, although he has had the privilege of educating students and physicians in training and lecturing at many national and international cardiology meetings, Dr. DiSalvo enjoys educating patients and their families even more, both in the clinic and at the bedside. Dr. Di Salvo is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Apoplexy, Atrial Fibrillation, Pulmonary Edema, Cardiac Ablation, and Pacemaker Implantation. Dr. Di Salvo is currently accepting new patients.

Jessica Atkins, MD, specializes in Heart Failure & Transplant and is located in Charleston, SC. Dr. Atkins is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Heart Failure, Cardiogenic Shock, Pulmonary Edema, Cardiomyopathy, and Heart Transplant. Dr. Atkins is currently accepting new patients.